Blood pressure, cholesterol, and stroke in eastern Asia

Lancet

Volumn 352, Issue 9143, 1998, Pages 1801-1807

  Rodgers, A ^a   MacMahon, S ^a   Yee, T ^a   Clark, T ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ARTICLE; ASIA; AUTOPSY; BLOOD PRESSURE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHINA; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; STROKE;

EID: 0032488346     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03454-0     Document Type: Article

References (37)

1. 1 Murray CJL, Lopez AD. Global pattern of cause of death and burden of disease in 1990, with projections to 2020-investing in health research and development: reportof the ad hoc committee on health research relating to future intervention options. Geneva: WHO, 1996.
2. 2 Sudlow CLM, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997; 28: 491-99.
3. 3 MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease - part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
4. 4 Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 45 000 people in 45 prospective cohorts. Lancet 1995; 346: 1647-53.
5. 5 Cox DR. Regression models and life tables (with discussion). J R Statist Soc B 1972; 34: 187-220.
6. 6 How Lin C, Shimzu Y, Kato H, et al. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship between type and risk factors. Stroke 1984; 15: 653-60.
7. 7 Ueda K, Hasuo Y, Kiyohara, et al. Intracerebral haemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke 1988; 19: 48-52.
8. 8 Hosmer DN, Lemeshow S. Applied logistic regression. New York: Wiley and Sons, 1989.
9. 9 Carroll RJ, Stefanski LA. Measurement error, instrumental variables and corrections for attenuation with applications to meta-analyses. Statist Med 1994; 13: 1265-82.
10. 10 Okada H, Horibe H, Ohno Y, Hayakawa N, Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi - part 1, evaluation of risk factors in the occurrence of cerebral haemorrhage and thrombosis. Stroke 1976; 7: 599-607.
11. 11 Tamakoshi A, Ohno Y, Yamada T, et al. Serum cholesterol and cancer mortality in Japanese civil service workers: findings from a nested case-control study. J Epidemiol 1993; 3: 99-107.
12. 12 Hashimoto R, Adachi H, Tsuruta M. Association of hyperinsulinemia and serum free fatty acids with serum high density lipoprotein-cholesterol. J Atheroscler Thromb 1995; 2: 53-59.
13. 13 Ito Y, Suzuki S, Yagyu K, Sasaki R, Suzuki K, Aoki K. Relationship between serum carotenoid levels and cancer death rates in the residents living in a rural area of Hokkaido, Japan. J Epidemiol 1997; 7: 1-8.
14. 14 Liu L, Yun L, Tao S, Wang J. A five year follow-up study of hypertension in 10 450 steel workers. Chin Med J 1979; 92: 719-22.
15. 15 Li Z, Zhang H, Dong Y. Preliminary analysis on mortality and risk factors in a Chinese population. Asian Pacific Congress on Vascular Disease Prevention, 1996: 49 (abstr W1.1A).
16. 16 Zhou B, Wu Y, Yang J, et al. Associations between dietary pattern, clustering of risk factors, and incidence of cardiovascular diseases in Chinese populations. Asian Pacific Congress on Vascular Disease Prevention, 1996: 49 (abstr W1.1B).
17. 17 Wu X, Hao J, Wang J, et al. A prospective study on risk factors of coronary heart disease among male workers in Capitol Iron & Steel Company: the relationship between blood pressure, cholesterol and smoking with CHD. Chin Circ J 1991; 6: 127-30.
18. 18 Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991; 303: 276-82.
19. 19 Xu Z, Zhang H, Hu D. A community cohort study on risk factors of strokes in Shanghai: a Cox regression analysis in 15 885 subjects. Chin J Epidemiol 1994; 15: 94-98.
20. 20 He Y, Lam TH. A prospective study on smoking and death from coronary heart disease in Xi'an, China. Am J Epidemiol 1996; 143: S48 (abstr).
21. 21 Neaton JD, Blackburn H, Jacobs D, Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992; 152: 1490-500.
22. 22 Benfante R, Yano K, Hwang L-J, Curb D, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke 1994; 25: 814-20.
23. 23 Gatchev O, Rastam L, Lindberg G, Gullberg B, Eklund G, Isacsson S-O. Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. Ann Epidemiol 1993; 3: 403-09.
24. 24 Szatrowski TP, Peterson AV, Shimizu Y, et al. Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chron Dis 1984; 37: 569-84.
25. 25 Yano K, Reed DM, MacLean CJ. Serum cholesterol and haemorrhagic stroke in the Honolulu Heart Program. Stroke 1989; 20: 1460-65.
26. 26 Iribarren C, Jacobs DR, Sadler M, Claxton AJ, Sidney S. Low total serum cholesterol and intracerebral haemorrhagic stroke: is the association confined to elderly men? (The Kaiser Permanente Medical Care Program). Stroke 1996; 27: 1993-98.
27. 27 Hebert PR, Gaziano JM, Sau Chan K, Hennekens C. Cholesterol lowering with statin drugs, risk of stroke and total mortality. JAMA 1997; 278: 313-21.
28. 28 Law MR, Thompson SG, Wald NJ. Assessing possible hazards in reducing serum cholesterol. BMJ 1994; 308: 373-79.
29. 29 Shimamoto T, Komachi Y, Inada H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-15.
30. 30 Murray CJL. Re-thinking DALYs. In: Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Havard University Press, 1996; 295-324.
31. 31 Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III-analysis of data from trials of salt reduction. BMJ 1991; 302: 819-24.
32. 32 Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996; 312: 1249-53.
33. 33 He J, Whelton PK. Role of sodium reduction in the treatment and prevention of hypertension. Curr Opin Cardiol 1997; 12: 202-07.
34. 34 Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure - meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624-32.
35. 35 Fagard RH. The role of exercise in blood pressure control: supportive evidence. J Hypertens 1995; 13: 1223-27.
36. 36 MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8 (suppl B): 57-70.
37. 37 MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1994; 4: 265-71.